Robert Sherwin, MD, YCCI Director
The National Center for Advancing Translational Sciences (NCATS) is promoting partnerships with industry to accelerate the development of new therapeutics. YCCI has embraced this concept by partnering with the Office of Cooperative Research (OCR) on pilot awards for promising translational projects that may ultimately become commercial products. We are also working with the Yale Entrepreneurial Institute (YEI) to bring new funding opportunities to the attention of investigators. YEI offers a number of opportunities related to research and boasts a staff with both scientific and business know-how. YCCI and YEI co-sponsored a symposium this fall on SBIR and STTR grants that sheds light on negotiating these programs. We hope that these efforts will speed up the process of bringing innovative discoveries from the lab to the clinic.
While we continue to point the way to funding sources for research, we also recognize the need to improve the quality of clinical research. We are devoting more resources to guide investigators through the complexities of clinical research by providing specialized expertise in regulatory issues and IND applications. Our quality assurance unit is expanding its capabilities with the addition of staff members to monitor research studies, and provide educational programs to help investigators understand increasingly complex regulatory requirements. Symposia held this fall were designed to help research faculty successfully navigate the complexities of conducting clinical research. Speakers from academic medical centers shared lessons learned, and discussed the policies and structures they have put in place to support best practices in research. We encourage you to join us for the last of the series in December. As always, please feel free to contact us for training opportunities and assistance with clinical and translational research studies.
Robert Sherwin, MD